Merck Repatriates $15 Bil. In Overseas Cash, Takes $740 Mil. Related Charge
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck had previously disclosed its intention to repatriate cash, but declined to specify the amount. The related charge – offset by a $100 mil. tax benefit – lowered second quarter income by 29¢ per share. Pfizer has repatriated a total of $36.6 bil. in overseas cash over two quarters.
You may also be interested in...
Pazdur’s Big Moment: ‘Project Odyssey’ Webinar Gives Oncology Chief External Buy-In On His Ideas To Revamp ODAC
OCE Director Richard Pazdur is known for cultivating 'Pazdur moments' during advisory committees when he feels the conversation has gone off track. A recent webinar with ODAC members created a perfect opportunity to promote his agenda.
Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks
All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?
US FDA Advisory Panels May Look Different Across Centers, Despite Efforts To Standardize Process
As FDA is readying to go back to in-person advisory committee meetings this fall, the centers have different ideas about how to use their expert panels.